Zobrazeno 1 - 10
of 320
pro vyhledávání: '"Hepatitis C antibody"'
Autor:
Jin Gu Kang, Myoung Kuk Jang, Jung Hee Kim, Jang Han Jung, Ji Won Park, Sung Eun Kim, Sang Hoon Park, Myung Seok Lee, Ki Tae Suk, Dong Joon Kim, Hyoung Su Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 3, Pp 362-371 (2023)
Background/Aims Although anti-hepatitis C virus (HCV) assay is widely used to screen for HCV infection, it has a high false-positive (FP) rate in low-risk populations. We investigated the accuracy of anti-HCV signal-to-cutoff (S/CO) ratio to distingu
Externí odkaz:
https://doaj.org/article/42eaf79331a84b0099993400cc9e578b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hua-Ping Huang, Guo-Sheng Yuan, Yu-Chen Zhou, Cheng-Guang Hu, Jun-Wei Liu, Shuai Yuan, Yu-Rong Qiu, Yi-Ping Li, Yong-Yuan Zhang, Yuan-Ping Zhou
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 11, Iss 2, Pp 171-176 (2018)
Objective: To determine the frequency of anti-HCV antibody positivity in patients with non-liver disease complaints, to explore whether anti-HCV positive patients had been properly advised and visited hepatologists for further assessments, and to inv
Externí odkaz:
https://doaj.org/article/65402a44e7e745b38a5a211d720b465d
Autor:
Ann Winters, Nadine Kela-Murphy, Emily Harrison, Marie P. Bresnahan, Charu M. Verma, Miranda S. Moore, Jessie Schwartz
Publikováno v:
Journal of Public Health Management and Practice. 28:E413-E420
CONTEXT As of 2015, an estimated 116000 New York City (NYC) residents had chronic hepatitis C, many of them undiagnosed. Although effective medications have been available since 2014 with the advent of direct-acting antivirals, provider-based barrier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ca281208d0ceb733ec58160d7d95f8
https://doi.org/10.1097/phh.0000000000001402
https://doi.org/10.1097/phh.0000000000001402
Autor:
Wesley Durkalski, Robert D. Allison, Naomi Tamez, John R. Litaker, Richard P. Taylor, Carlos Lopez Bray
Publikováno v:
Population Health Management
Infection with the hepatitis C virus (HCV) is the most commonly reported bloodborne infection in the United States. Individuals born between 1945–1965, the baby boomers, account for approximately 75% of all chronic HCV infections in the United Stat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebce36b5587bbdb625cfe4cd271d18f9
https://doi.org/10.1089/pop.2020.0214
https://doi.org/10.1089/pop.2020.0214
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-6 (2021)
Harm Reduction Journal
Harm Reduction Journal
Background Between December 2018 and January of 2019, we evaluated the accuracy of the point-of-care Hepatitis C (HCV) antibody test (POC; OraQuick HCV) used at a community-based needle and syringe exchange program serving persons who inject drugs in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245a87586336730d191986bb0f74a03e
https://doaj.org/article/4fb6e6368f624cabb59743898fb54824
https://doaj.org/article/4fb6e6368f624cabb59743898fb54824
Publikováno v:
Laboratory Medicine and Quality Assurance. 43:37-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b965ba333e727866bf5fa488bb72bc1
https://doi.org/10.15263/jlmqa.2021.43.1.37
https://doi.org/10.15263/jlmqa.2021.43.1.37
Publikováno v:
The Journal of the American Board of Family Medicine. 33:1016-1019
In the United States, national guidelines recommend screening adults born between 1945 and 1965 for hepatitis C, but screening rates in this population continue to be low. We added a hepatitis C screening reminder to the Epic Electronic Health Record
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ce0e973313cca7ad5bf4bdb214a259
https://doi.org/10.3122/jabfm.2020.06.190440
https://doi.org/10.3122/jabfm.2020.06.190440
Autor:
Robert Koch-Institut, Christoph Sarrazin, Schweizerische Gesellschaft für Gastroenterologie, Thomas Berg, Gesellschaft für Pädiatrische Gastroenterologie und Ernährung, Heiner Wedemeyer, Verdauungs und Stoffwechselkrankheiten Deutsche Gesellschaft für Gastroenterologie, Stefan Mauss, Deutsche Arbeitsgemeinschaft niedergelassener Ärzte für die Versorgung HIV-Infizierter, Österreichische Gesellschaft für Gastroenterologie und Hepatologie, Tim Zimmermann, Stefan Zeuzem, Holger Hinrichsen, Deutsche Leberstiftung
Publikováno v:
Zeitschrift für Gastroenterologie. 58:1110-1131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30eddaea31ab76b7a53d250a7f96dc84
https://doi.org/10.1055/a-1226-0241
https://doi.org/10.1055/a-1226-0241